Obstet Gynecol Sci.  2016 Jan;59(1):1-8. 10.5468/ogs.2016.59.1.1.

Clinical characteristics and outcome of cancer diagnosed during pregnancy

Affiliations
  • 1Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. drmaxmix.choi@samsung.com

Abstract


OBJECTIVE
The aim of this study is to describe the clinical characteristics and outcome of cancer diagnosed during pregnancy.
METHODS
This is a retrospective cohort study of women who were diagnosed with cancer during pregnancy at a tertiary academic hospital between 1995 and 2013. Maternal characteristics, gestational age at diagnosis, and type, stage, symptoms and signs of cancer for each patient were retrieved from the medical records. The cancer treatment, pregnancy management and the subsequent perinatal and maternal outcomes for each cancer were assessed.
RESULTS
A total of 87 women were diagnosed with cancer during pregnancy (172.6 cases per 100,000 deliveries). The most common cancer was breast cancer (n=20), followed by gastrointestinal (n=17), hematologic (n=13), thyroid (n=11), central nervous system (n=7), cervical (n=7), ovarian (n=5), lung (n=3), and other cancers (n=4). Eighteen (20.7%) patients terminated their pregnancies. In the 69 (79.3%) patients who maintained their pregnancies, one patient miscarried and 34 patients delivered preterm. Of the preterm babies, 24 (70.6%) were admitted to the neonatal intensive care unit and 3 (8.8%) of those expired. The maternal mortality rate was 31.0%, with highest rate seen with lung cancers (66.7%), followed by gastrointestinal (50.0%), central nervous system (50.0%), hematologic (30.8%), breast (25.0%), ovarian (20.0%) cervical (14.3%), and thyroid cancers (0%).
CONCLUSION
The clinical characteristics and outcome of cancer during pregnancy were highly variable depending on the type of cancer. However, timely diagnosis and appropriate management of cancer during pregnancy may improve both maternal and neonatal outcome.

Keyword

Maternal mortality; Neoplasms; Pregnancy; Pregnancy outcome

MeSH Terms

Breast
Breast Neoplasms
Central Nervous System
Cohort Studies
Diagnosis
Female
Gestational Age
Humans
Infant, Newborn
Intensive Care, Neonatal
Lung
Lung Neoplasms
Maternal Mortality
Medical Records
Pregnancy Outcome
Pregnancy*
Retrospective Studies
Thyroid Gland

Cited by  1 articles

Nurse's Perception of Cancer Treatment during Pregnancy
Hae Won Kim, Eun Ju Lee, Seo Yun Kim, Young Jin Lee, Hye Young Ahn
Asian Oncol Nurs. 2019;19(1):27-36.    doi: 10.5388/aon.2019.19.1.27.


Reference

1. Korean Statistical Information Service. Cause of death statistics: 1995-2013 web-based report [Internet]. Daejeon: Korean Statistical Information Service;c2014. cited 2014 Nov 3. Available from: http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B34E02&vw_cd=&list_id=&scrId=&seqNo=&lang_mode=ko&obj_var_id=&itm_id=&conn_path=K1&path=#.
2. Weisz B, Meirow D, Schiff E, Lishner M. Impact and treatment of cancer during pregnancy. Expert Rev Anticancer Ther. 2004; 4:889–902.
3. Korean Statistical Information Service. Cancer incidence rate: 2012 web-based report [Internet]. Daejeon: Korean Statistical Information Service;c2015. cited 2015 Jan 12. Available from: http://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_117N_A00023&vw_cd=MT_ZTITLE&list_id=101_11744&seqNo=&lang_mode=ko&language=kor&obj_var_id=&itm_id=&conn_path=E1.
4. Korean Statistical Information Service. Simulated average childbearing age: 1993-2013 web-based report [Internet]. Daejeon: Korean Statistical Information Service;c2014. cited 2014 Aug 26. http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B81A20&vw_cd=MT_ZTITLE&list_id=A21_6&seqNo=&lang_mode=ko&language=kor&obj_var_id=&itm_id=&conn_path=E1#.
5. Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010; 28:683–689.
6. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002; 7:279–287.
7. Weisz B, Schiff E, Lishner M. Cancer in pregnancy: maternal and fetal implications. Hum Reprod Update. 2001; 7:384–393.
8. Dunkelberg JC, Barakat J, Deutsch J. Gastrointestinal, pancreatic, and hepatic cancer during pregnancy. Obstet Gynecol Clin North Am. 2005; 32:641–660.
9. US Cancer Statistics Working Group. United States cancer statistics: 1999-2011 incidence and mortality web-based report [Internet]. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute;c2014. cited 2014 Dec 24. http://www.cdc.gov/cancer/npcr/pdf/USCS_FactSheet.pdf.
10. Antonelli NM, Dotters DJ, Katz VL, Kuller JA. Cancer in pregnancy: a review of the literature. Part I. Obstet Gynecol Surv. 1996; 51:125–134.
11. Andersson TM, Johansson AL, Fredriksson I, Lambe M. Cancer during pregnancy and the postpartum period: a population-based study. Cancer. 2015; 121:2072–2077.
12. Eibye S, Kjaer SK, Mellemkjaer L. Incidence of pregnancyassociated cancer in Denmark, 1977-2006. Obstet Gynecol. 2013; 122:608–617.
13. Cardonick E. Pregnancy-associated breast cancer: optimal treatment options. Int J Womens Health. 2014; 6:935–943.
14. Lee HY, Chay WY, Tang MB, Chio MT, Tan SH. Melanoma: differences between Asian and Caucasian patients. Ann Acad Med Singapore. 2012; 41:17–20.
15. National Cancer Information Center. Cancer prevalence by generation: 2012 web-based report [Internet]. Goyang: National Cancer Information Center;c2014. cited 2014 Dec 24. http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040103000000.
16. Chung JH. Cost-of-illness trend of thyroid gland disease in Korea. Endocrinol Metab (Seoul). 2014; 29:248–250.
17. Han MA, Choi KS, Lee HY, Kim Y, Jun JK, Park EC. Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev. 2011; 12:1657–1663.
18. Lishner M. Cancer in pregnancy. Ann Oncol. 2003; 14:Suppl 3. iii31–iii36.
19. Oh SE, Kim HJ, Choi SJ, Oh SY, Roh CR, Kim JH. A case of huge retroperitoneal liposarcoma in pregnancy. Obstet Gynecol Sci. 2014; 57:236–239.
20. Abramowicz JS. Benefits and risks of ultrasound in pregnancy. Semin Perinatol. 2013; 37:295–300.
21. Bulas D, Egloff A. Benefits and risks of MRI in pregnancy. Semin Perinatol. 2013; 37:301–304.
22. ACOG Committee on Obstetric Practice. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol. 2004; 104:647–651.
23. Fenig E, Mishaeli M, Kalish Y, Lishner M. Pregnancy and radiation. Cancer Treat Rev. 2001; 27:1–7.
24. Brent RL. The effect of embryonic and fetal exposure to Xray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol. 1989; 16:347–368.
25. Savas N. Gastrointestinal endoscopy in pregnancy. World J Gastroenterol. 2014; 20:15241–15252.
26. Cappell MS. The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin North Am. 2003; 32:123–179.
27. Jaspers VK, Gillessen A, Quakernack K. Gastric cancer in pregnancy: do pregnancy, age or female sex alter the prognosis? Case reports and review. Eur J Obstet Gynecol Reprod Biol. 1999; 87:13–22.
28. Pereg D, Koren G, Lishner M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev. 2008; 34:302–312.
29. Malangoni MA. Gastrointestinal surgery and pregnancy. Gastroenterol Clin North Am. 2003; 32:181–200.
30. Amant F, Han SN, Gziri MM, Vandenbroucke T, Verheecke M, Van Calsteren K. Management of cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015; 29:741–753.
31. Aviles A, Diaz-Maqueo JC, Talavera A, Guzman R, Garcia EL. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol. 1991; 36:243–248.
32. Lishner M, Koren G. Cancer chemotherapy during pregnancy: consortium of cancer in pregnancy evidence. Can Fam Physician. 2001; 47:41–42.
33. Amant F, Van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012; 13:256–264.
34. Cunningham FG, editor. Williams obstetrics. 24th ed. New York (NY): McGraw-Hill;2014.
Full Text Links
  • OGS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr